 V300_crop.jpg)
Aspect Biosystems
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
887 Great Northern Way 500, Vancouver, B...Phone Number
(604) 263-0502Website
www.aspectbiosystems.comRevenue
$28.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Aspect Biosystems
Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. The companys proprietary Lab-on-a-Printer platform technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate the discovery and development of new drugs and therapies.Explore more
Aspect Biosystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aspect Biosystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Aspect Biosystems has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Aspect Biosystems
Aspect Biosystems, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Aspect Biosystems had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aspect Biosystems recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Aspect Biosystems launches new products
Funding: Get notified immidiatlly once Aspect Biosystems has new funding data
Check out if Aspect Biosystems is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Aspect Biosystems as Masked Content
Find more new buyers
Compare Similar Companies to Aspect Biosystems
Compare insights from companies similar to Aspect Biosystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aspect Biosystems is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aspect Biosystems is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aspect Biosystems.
Aspect Biosystems financials insights
Gather financial insights about Aspect Biosystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Other Financing Round
$1M
2020
Series A
$20M
2025
Series B
$115M
2026
Unspecified
$79M
Aspect Biosystems Tech Stack
A closer look at the technologies used by Aspect Biosystems
Most Recent Scoops
Funding
Funding
Funding
Funding
Promotion
Executive Move
Leela Paris has recently been promoted from Senior Vice President, Technical Operations to the role of Chief Technical Operations Officer.
Executive Moves, Promotion
Funding
Funding
Executive Move
Executive Moves, Board of Directors
Aspect Biosystems News & Media
Feds invest $79 million in Aspect Biosystems to develop 3D-printed tissue treatment
Investment supports $280 million project to “significantly enhance” Aspect’s clinical development capabilities. The post Feds invest $79 million in Aspect Biosystems to develop 3D-printed tissue treatment first appeared on BetaKit.After Cell Therapy Retreat, Novo Offloads Technologies in Deepened Aspect Pact
Novo Nordisk pulled back from cell therapies last October, scrapping development of a type 1 diabetes therapy and laying off most employees working on this modality.Aspect Biosystems and Novo Nordisk enter new phase of partnership to develop curative medicines for diabetes
Novo Nordisk and Aspect Biosystems today announced they are entering a new phase of their partnership to develop advanced cellular medicines for diabetes.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Aspect Biosystems
Sign Up For FreeTo access detailed company insights
Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. The companys proprietary Lab-on-a-Printer platform technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition... Read More
